Thermo Fisher Scientific SG&A increased by 5.0% to $2.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $2.08B to $2.18B. Over 3 years (FY 2021 to FY 2024), SG&A shows relatively stable performance with a 2.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
Metric ID:
selling_general_and_administrativeHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$42.00M | $59.00M | $7.97B | $2.28B | $2.21B | $2.21B | $2.30B | $2.12B | $2.15B | $2.05B | $2.13B | $2.18B | $2.11B | $2.10B | $2.20B | $2.08B | $2.18B |
| QoQ Change | — | +240.5% | >999% | -71.4% | -3.0% | -0.0% | +4.1% | -7.8% | +1.2% | -4.5% | +4.1% | +2.4% | -3.3% | -0.6% | +5.0% | -5.7% | +5.0% |
| YoY Change | — | — | — | — | >999% | >999% | -71.2% | -6.9% | -2.9% | -7.2% | -7.3% | +3.0% | -1.6% | +2.4% | +3.3% | -4.8% | +5.0% |
Range-$42.00M – $7.97B
CAGR+168.4%
Avg YoY Growth+685.7%
Median YoY Growth-1.6%
Business Segments
| Segment | Q3 '25 | Q1 '26 |
|---|---|---|
| Laboratory Products and Biopharma Services | $582.00M | $597.00M |
| Life Sciences Solutions | $470.00M | $496.00M |
| Analytical Instruments | $307.00M | $313.00M |
| Specialty Diagnostics | $175.00M | $177.00M |
| Total | — | $2.18B |
SG&A at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's sg&a?
- Thermo Fisher Scientific (TMO) reported sg&a of $2.18B in Q1 2026.
- How has Thermo Fisher Scientific's sg&a changed year-over-year?
- Thermo Fisher Scientific's sg&a increased by 5.0% year-over-year, from $2.08B to $2.18B.
- What is the long-term trend for Thermo Fisher Scientific's sg&a?
- Over 3 years (2021 to 2024), Thermo Fisher Scientific's sg&a has grown at a 2.4% compound annual growth rate (CAGR), from $8.01B to $8.60B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.